Your browser doesn't support javascript.
loading
Thiazolidinediones (TZDs) enhance insulin secretory response via GPR40 and adenylate cyclase (AC).
Hwang, Mina; Kim, Hyo-Sup; Jin, Sang-Man; Hur, Kyu Yeon; Kim, Jae-Hyeon; Lee, Moon-Kyu.
Affiliation
  • Hwang M; Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim HS; Division of Endocrinology and Metabolism, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Jin SM; Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hur KY; Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JH; Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee MK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Eulji University Hospital, Uijeongbu Medical Center, Eulji University, Uijeongbu, Korea.
J Cell Physiol ; 236(12): 8137-8147, 2021 12.
Article in En | MEDLINE | ID: mdl-34133753

Full text: 1 Database: MEDLINE Main subject: Adenylyl Cyclases / Thiazolidinediones / Insulin-Secreting Cells / Insulin Secretion Limits: Animals / Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Adenylyl Cyclases / Thiazolidinediones / Insulin-Secreting Cells / Insulin Secretion Limits: Animals / Humans Language: En Year: 2021 Type: Article